Lexaria Bioscience Corp.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-4.0M | $-4.0M | — | $410.0K |
| FY2022 | $-4.9M | $-4.9M | $49.2K | $752.6K |
| FY2023 | $-5.9M | $-5.9M | $33.7K | $170.4K |
| FY2024 | $-5.0M | $-5.0M | $43.0K | $492.2K |
| FY2025 | $-10.5M | $-10.5M | $24.6K | $859.5K |